Amylyx Pharmaceuticals Inc's total assets for Q3 2024 were $250.71M, a decrease of -24.52% from the previous quarter. AMLX total liabilities were $54.51M for the fiscal quarter, a -23.07% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.